Projects per year
Fingerprint
Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Finished
-
Administrative Core
Konopleva, M., Konopleva, M. M. Y. & Kantarjian, H.
9/1/18 → 8/31/23
Project: Research project
-
AML treatment: conventional chemotherapy and emerging novel agents
Forsberg, M. & Konopleva, M., May 2024, In: Trends in Pharmacological Sciences. 45, 5, p. 430-448 19 p.Research output: Contribution to journal › Review article › peer-review
-
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia
Short, N. J., Jabbour, E., Jain, N., Senapati, J., Nasr, L., Haddad, F. G., Li, Z., Hsiao, Y. C., Yang, J. J., Pemmaraju, N., Ohanian, M., Wierda, W. G., Montalban-Bravo, G., Borthakur, G., Han, L., Xiao, L., Huang, X., Abramova, R., Zhao, M., Garris, R., & 3 others , Feb 27 2024, In: Blood Advances. 8, 4, p. 909-915 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
Short, N. J., Daver, N., Dinardo, C. D., Kadia, T., Nasr, L. F., Macaron, W., Yilmaz, M., Borthakur, G., Montalban-Bravo, G., Garcia-Manero, G., Issa, G. C., Chien, K. S., Jabbour, E., Nasnas, C., Huang, X., Qiao, W., Matthews, J., Stojanik, C. J., Patel, K. P., Abramova, R., & 4 others , May 1 2024, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 42, 13, p. 1499-1508 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro
Hurrish, K. H., Su, Y., Patel, S., Ramage, C. L., Zhao, J., Temby, B. R., Carter, J. L., Edwards, H., Buck, S. A., Wiley, S. E., Hüttemann, M., Polin, L., Kushner, J., Dzinic, S. H., White, K., Bao, X., Li, J., Yang, J., Boerner, J., Hou, Z., & 9 others , Feb 2024, In: Biochemical Pharmacology. 220, 115981.Research output: Contribution to journal › Article › peer-review
-
Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))
Tian, Z., Shi, C., Yang, G., Allen, J. K., Shi, Q., Al-Shami, A., Olson, J. W., Smith, M. G., Chang, Q., Kaur, J., You, J., Lofton, T. E., Gonzalez, M. A., Zhang, Q., Zha, D. X., Tasian, S. K., Jain, N., Konopleva, M. Y., Heffernan, T. & Molldrem, J. J., Jan 1 2024, In: Leukemia. 38, 1, p. 226 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access